• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Escape of HIV-1 envelope glycoprotein from the restriction of infection by IFITM3.HIV-1包膜糖蛋白逃脱IFITM3对感染的限制
J Virol. 2021 Mar 1;95(5). doi: 10.1128/JVI.01994-20. Epub 2020 Dec 9.
2
The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.HIV-1包膜蛋白的V3环决定病毒对IFITM3损害病毒感染性的易感性。
J Virol. 2017 Mar 13;91(7). doi: 10.1128/JVI.02441-16. Print 2017 Apr 1.
3
IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.IFITM3 减少逆转录病毒包膜的丰度和功能,并且被糖基化 Gag 拮抗。
mBio. 2020 Jan 21;11(1):e03088-19. doi: 10.1128/mBio.03088-19.
4
Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.HIV-1感染过程中SERINC5和IFITM3对HIV-1包膜糖蛋白的压差
J Virol. 2020 Jul 30;94(16). doi: 10.1128/JVI.00514-20.
5
Distinct mechanisms regulate exposure of neutralizing epitopes in the V2 and V3 loops of HIV-1 envelope.不同的机制调节HIV-1包膜V2和V3环中中和表位的暴露。
J Virol. 2014 Nov;88(21):12853-65. doi: 10.1128/JVI.02125-14. Epub 2014 Aug 27.
6
IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters.IFITM1 和 IFITM3 蛋白在不破坏包膜糖蛋白簇的情况下抑制 HIV-1 子代的感染性。
Viruses. 2023 Dec 7;15(12):2390. doi: 10.3390/v15122390.
7
Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines.免疫复合物疫苗对 HIV-1 包膜 V1V2 和 V3 区抗体反应的调节。
Front Immunol. 2018 Oct 26;9:2441. doi: 10.3389/fimmu.2018.02441. eCollection 2018.
8
Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer.HIV-1包膜三聚体的可塑性与表位暴露
J Virol. 2017 Aug 10;91(17). doi: 10.1128/JVI.00410-17. Print 2017 Sep 1.
9
The V1V2 domain and an N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12.HIV-1 包膜糖蛋白的 V1V2 结构域和 V3 环中的一个 N-连接糖基化位点调节了对人类广谱中和抗体 2G12 的中和敏感性。
J Virol. 2011 Apr;85(7):3642-8. doi: 10.1128/JVI.02424-10. Epub 2011 Jan 19.
10
Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.人类免疫缺陷病毒 1 包膜糖蛋白的双重运输途径调节未切割寡聚体从病毒粒子中的选择性排除。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01369-20.

引用本文的文献

1
HSV1-induced enhancement of productive HIV-1 replication is associated with interferon pathway downregulation in human macrophages.单纯疱疹病毒 1 诱导的人类巨噬细胞中 HIV-1 复制的增强与干扰素通路下调有关。
Mem Inst Oswaldo Cruz. 2024 Oct 28;119:e240102. doi: 10.1590/0074-02760240102. eCollection 2024.
2
HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes.HIV-1抑制IFITM3的表达以促进巨核细胞的感染。
J Mol Cell Biol. 2025 Mar 21;16(9). doi: 10.1093/jmcb/mjae042.
3
The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies.干扰素诱导跨膜蛋白的抗病毒活性和病毒逃逸策略。
Viruses. 2024 May 6;16(5):734. doi: 10.3390/v16050734.
4
Role of Viral Envelope Proteins in Determining Susceptibility of Viruses to IFITM Proteins.病毒包膜蛋白在决定病毒对 IFITM 蛋白的易感性中的作用。
Viruses. 2024 Feb 5;16(2):254. doi: 10.3390/v16020254.
5
IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters.IFITM1 和 IFITM3 蛋白在不破坏包膜糖蛋白簇的情况下抑制 HIV-1 子代的感染性。
Viruses. 2023 Dec 7;15(12):2390. doi: 10.3390/v15122390.
6
A nano-luciferase expressing human coronavirus OC43 for countermeasure development.一种表达纳米荧光素酶的人冠状病毒 OC43,用于开发对策。
Virus Res. 2024 Jan 2;339:199286. doi: 10.1016/j.virusres.2023.199286. Epub 2023 Dec 5.
7
An atlas of immune cell transcriptomes in human immunodeficiency virus-infected immunological non-responders identified marker genes that control viral replication.在人类免疫缺陷病毒感染的免疫无应答者的免疫细胞转录组图谱中,鉴定出了控制病毒复制的标记基因。
Chin Med J (Engl). 2023 Nov 20;136(22):2694-2705. doi: 10.1097/CM9.0000000000002918. Epub 2023 Nov 1.
8
Transmembrane domain of IFITM3 is responsible for its interaction with influenza virus HA subunit.IFITM3 的跨膜结构域负责其与流感病毒 HA 亚基的相互作用。
Virol Sin. 2022 Oct;37(5):664-675. doi: 10.1016/j.virs.2022.07.002. Epub 2022 Jul 6.
9
HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals.HIV-1 包膜糖蛋白的蛋白水解切割可保护感染细胞免受感染个体血浆中 ADCC 介导的杀伤。
Viruses. 2021 Nov 6;13(11):2236. doi: 10.3390/v13112236.
10
HIV-1 entry: Duels between Env and host antiviral transmembrane proteins on the surface of virus particles.HIV-1 进入:病毒粒子表面的Env 和宿主抗病毒跨膜蛋白之间的决斗。
Curr Opin Virol. 2021 Oct;50:59-68. doi: 10.1016/j.coviro.2021.07.005. Epub 2021 Aug 12.

本文引用的文献

1
Opposing activities of IFITM proteins in SARS-CoV-2 infection.干扰素诱导跨膜蛋白(IFITM)在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的相反作用
EMBO J. 2021 Feb 1;40(3):e106501. doi: 10.15252/embj.2020106501. Epub 2020 Dec 21.
2
IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.IFITM3 减少逆转录病毒包膜的丰度和功能,并且被糖基化 Gag 拮抗。
mBio. 2020 Jan 21;11(1):e03088-19. doi: 10.1128/mBio.03088-19.
3
Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity.干扰素诱导跨膜蛋白在抗病毒免疫中的功能参与
Front Microbiol. 2019 May 16;10:1097. doi: 10.3389/fmicb.2019.01097. eCollection 2019.
4
IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections.干扰素诱导跨膜蛋白基因、变体及其在病毒感染控制和发病机制中的作用。
Front Microbiol. 2019 Jan 8;9:3228. doi: 10.3389/fmicb.2018.03228. eCollection 2018.
5
IFITM3 directly engages and shuttles incoming virus particles to lysosomes.IFITM3 直接结合并将进入的病毒颗粒转运到溶酶体。
Nat Chem Biol. 2019 Mar;15(3):259-268. doi: 10.1038/s41589-018-0213-2. Epub 2019 Jan 14.
6
Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.干扰素诱导跨膜蛋白 3 通过分隔到携带病毒的内体中来阻止敏感但不耐药的病毒融合。
PLoS Pathog. 2019 Jan 14;15(1):e1007532. doi: 10.1371/journal.ppat.1007532. eCollection 2019 Jan.
7
Functional Mapping of Regions Involved in the Negative Imprinting of Virion Particle Infectivity and in Target Cell Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1.抗病毒蛋白诱导跨膜蛋白 3 对 HIV-1 病毒粒子感染性的负印迹作用及对靶细胞保护作用相关区域的功能图谱。
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.01716-18. Print 2019 Jan 15.
8
IFITM proteins inhibit HIV-1 protein synthesis.IFITM 蛋白抑制 HIV-1 蛋白合成。
Sci Rep. 2018 Sep 28;8(1):14551. doi: 10.1038/s41598-018-32785-5.
9
The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.干扰素诱导跨膜蛋白对 HIV-1 进入的抑制作用不依赖于辅助受体的使用。
Viruses. 2018 Aug 7;10(8):413. doi: 10.3390/v10080413.
10
Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.属于传播链的患者的 HIV-1 变体的包膜糖蛋白的表型特性。
AIDS. 2018 Sep 10;32(14):1917-1926. doi: 10.1097/QAD.0000000000001906.

HIV-1包膜糖蛋白逃脱IFITM3对感染的限制

Escape of HIV-1 envelope glycoprotein from the restriction of infection by IFITM3.

作者信息

Drouin Aurélie, Migraine Julie, Durand Marie-Alice, Moreau Alain, Burlaud-Gaillard Julien, Beretta Maxime, Roingeard Philippe, Bouvin-Pley Mélanie, Braibant Martine

机构信息

Université de Tours et CHRU de Tours, Inserm U1259, Tours, France.

Université de Tours et CHRU de Tours, Plateforme IBiSA de Microscopie Electronique, Tours, France.

出版信息

J Virol. 2021 Mar 1;95(5). doi: 10.1128/JVI.01994-20. Epub 2020 Dec 9.

DOI:10.1128/JVI.01994-20
PMID:33298540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8092819/
Abstract

Interferon-induced transmembrane protein 3 (IFITM3) is a cellular factor that reduces HIV-1 infectivity by an incompletely understood mechanism. We show here that viruses differing only in the envelope glycoprotein (Env) expressed on their surface have different sensitivities to IFITM3. Measurements of the sensitivity of viruses to neutralizing antibodies showed that IFITM3 increased the sensitivity of IFITM3-sensitive viruses to PG16, which targets the V1V2 loop, suggesting that IFITM3 promotes exposure of the PG16 epitope of IFITM3-sensitive viruses. Exchanges of V1V2 loops between the Env proteins of sensitive and resistant viruses revealed that V1V2 and V3 act together to modulate viral sensitivity to IFITM3. Co-immunoprecipitation experiments showed that IFITM3 interacted with both the precursor (gp160) and cleaved (gp120) forms of Env from IFITM3-sensitive viruses, but only with the precursor (gp160) form of Env from IFITM3-resistant viruses. This finding suggests that the interaction between the Env of resistant viruses and IFITM3 was inhibited once Env had been processed in the Golgi apparatus. This hypothesis was supported by immunofluorescence experiments, which showed a strong colocalization of IFITM3 with the Env of sensitive viruses, but only weak colocalization with the Env of resistant viruses on the plasma membrane of virus-producing cells. Together, these results indicate that IFITM3 interacts with Env, inducing conformational changes that may decrease viral infectivity. This antiviral action is, nevertheless, modulated by the nature of the Env, in particular its V1V2 and V3 loops, which after maturation may be able to escape this interaction. Interferon-induced transmembrane protein 3 (IFITM3) is a cellular factor that reduces HIV-1 infectivity by an incompletely understood mechanism. This study aimed to elucidate the role of the HIV-1 envelope glycoprotein (Env) in determining viral susceptibility to IFITM3. We found that viruses differing only in Env expressed on their surface had different sensitivities to IFITM3. By comparing the Env proteins of viruses that were highly sensitive or resistant to IFITM3, we obtained new insight in the mechanisms by which HIV-1 escapes this protein. We showed that IFITM3 interacts with the Env protein of sensitive viruses in virion-producing cells, inducing conformational changes that may decrease viral infectivity. However, this antiviral action is modulated by the nature of Env, particularly the V1V2 and V3 loops, which may be able to escape this interaction after processing in the Golgi.

摘要

干扰素诱导跨膜蛋白3(IFITM3)是一种细胞因子,其通过一种尚未完全了解的机制降低HIV-1的感染性。我们在此表明,仅在其表面表达的包膜糖蛋白(Env)不同的病毒对IFITM3具有不同的敏感性。对病毒对中和抗体敏感性的测量表明,IFITM3增加了对IFITM3敏感病毒对靶向V1V2环的PG16的敏感性,这表明IFITM3促进了对IFITM3敏感病毒的PG16表位的暴露。敏感病毒和抗性病毒的Env蛋白之间V1V2环的交换表明,V1V2和V3共同作用以调节病毒对IFITM3的敏感性。免疫共沉淀实验表明,IFITM3与来自对IFITM3敏感病毒的Env的前体(gp160)和裂解形式(gp120)相互作用,但仅与来自对IFITM3抗性病毒的Env的前体(gp160)形式相互作用。这一发现表明,一旦Env在高尔基体中被加工,抗性病毒的Env与IFITM3之间的相互作用就会受到抑制。免疫荧光实验支持了这一假设,该实验表明IFITM3与敏感病毒的Env在病毒产生细胞的质膜上有很强的共定位,但与抗性病毒的Env只有较弱的共定位。总之,这些结果表明IFITM3与Env相互作用,诱导可能降低病毒感染性的构象变化。然而,这种抗病毒作用受到Env性质的调节,特别是其V1V2和V3环,在成熟后可能能够逃避这种相互作用。干扰素诱导跨膜蛋白3(IFITM3)是一种细胞因子,其通过一种尚未完全了解的机制降低HIV-1的感染性。本研究旨在阐明HIV-1包膜糖蛋白(Env)在决定病毒对IFITM3易感性中的作用。我们发现仅在其表面表达的Env不同的病毒对IFITM3具有不同的敏感性。通过比较对IFITM3高度敏感或抗性的病毒的Env蛋白,我们对HIV-1逃避这种蛋白的机制有了新的认识。我们表明,IFITM3在病毒产生细胞中与敏感病毒的Env蛋白相互作用,诱导可能降低病毒感染性的构象变化。然而,这种抗病毒作用受到Env性质的调节,特别是V1V2和V3环,它们在高尔基体中加工后可能能够逃避这种相互作用。